Laser-Assisted In Situ Keratomileusis (LASIK) Lasers - Patient Labeling Recommendations: Draft Guidance for Industry and Food and Drug Administration Staff

Information

Type

Guidance

Regulated products

Medical Devices

Topics

Labeling, Premarket

Published

July 28, 2022

Last updated

October 7, 2022

Description

This document is a draft guidance for industry and FDA staff on labeling recommendations for LASIK lasers used in patient treatment.

Organization

Country / Region

United States

License

Other (Public Domain)

Feedback

Suggest an improvement to this page

Actions

Social networks

Embed